Devising global strategies for fracture-risk evaluation

Joint Bone Spine

Volumn 74, Issue 3, 2007, Pages 240-244

  Dargent Molina, Patricia ^a   Benhamou, Claude Laurent ^a   Cortet, Bernard ^a   Sutter, Bruno ^a   Thomas, Thierry ^a  

^a INSERM   (France)

Author keywords

Fractures; Osteoporosis; Risk; Screening

Indexed keywords

GLUCOCORTICOID;

BODY MASS; BONE DENSITY; BONE TURNOVER; COST EFFECTIVENESS ANALYSIS; FRACTURE; HUMAN; OSTEOPOROSIS; PRACTICE GUIDELINE; QUALITY ADJUSTED LIFE YEAR; RISK FACTOR; SHORT SURVEY; SMOKING; WORLD HEALTH ORGANIZATION;

FRACTURES, SPONTANEOUS; HUMANS; INTERNATIONAL COOPERATION; OSTEOPOROSIS; RISK FACTORS; WORLD HEALTH;

EID: 34248161051     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2006.11.004     Document Type: Short Survey

References (28)

1. Kanis J.A., Black D., Cooper C., Dargent P., Dawson-Hughes B., De Laet C., et al. A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int 13 (2002) 527-536
2. Kanis J.A. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359 (2002) 1929-1936
3. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis, Washington, DC; 1998.
4. Kanis J.A., Johnell O., Oden A., Dawson A., De Laet C., and Jonsson B. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12 (2001) 989-995
5. Kanis J.A., Johnell O., Oden A., De Laet C., Oglesby A., and Jonsson B. Intervention thresholds for osteoporosis. Bone 31 (2002) 26-31
6. Kanis J.A., Borgstrom F., Zethraeus N., Johnell O., Oden A., and Jonsson B. Intervention thresholds for osteoporosis in the UK. Bone 36 (2005) 22-32
7. Kanis J.A., Johnell O., Oden A., Borgstrom F., Johansson H., De Laet C., et al. Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden. Osteoporos Int 16 (2005) 6-14
8. Delmas P.D., Rizzoli R., Cooper C., and Reginster J.Y. Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation. Osteoporos Int 16 (2005) 1-5
9. Kanis J.A., Johnell O., De Laet C., Johansson H., Oden A., Delmas P., et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 35 (2004) 375-382
10. Kanis J.A., Johansson H., Oden A., Johnell O., De Laet C., Eisman J.A., et al. A family history of fracture and fracture risk: a meta-analysis. Bone 35 (2004) 1029-1037
11. Kanis J.A., Johnell O., Oden A., Johansson H., De Laet C., Eisman J.A., et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int 16 (2005) 155-162
12. De Laet C., Kanis J.A., Oden A., Johanson H., Johnell O., Delmas P., et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16 (2005) 1330-1338
13. Kanis J.A., Johansson H., Oden A., Johnell O., de Laet C., Melton I.L., et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19 (2004) 893-899
14. Looker A.C., Bauer D.C., Chesnut C.H., Gundberg C.M., Hochberg M.C., Klee G., et al. Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporos Int 11 (2000) 467-480
15. Delmas P.D., Eastell R., Garnero P., Seibel M.J., and Stepan J. The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 6 (2000) S2-S17
16. Dargent-Molina P., Favier F., Grandjean H., Baudoin C., Schott A.M., Hausherr E., et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet 348 (1996) 145-149 Erratum in: Lancet 1996;348:416
17. Cummings S.R., Nevitt M.C., Browner W.S., Stone K., and And A.L. Risk factors for hip fracture in white women. N Engl J Med 332 (1995) 767-773
18. Black D.M., Palermo L., and Grima D.T. Developing better economic models of osteoporosis: considerations for the calculation of the relative risk of fracture. Value Health 9 (2006) 54-58
19. Dargent-Molina P., Piault S., and Breart G. Identification of women at increased risk of osteoporosis: no need to use different screening tools at different ages. Maturitas 54 (2006) 55-64
20. McClung M.R., Geusens P., Miller P.D., Zippel H., Bensen W.G., Roux C., et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344 (2001) 333-340
21. Schott A.M., Dargent-Molina P., and Meunier P.J. The effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344 (2001) 1721
22. Black D.M., Steinbuch M., Palermo L., Dargent-Molina P., Lindsay R., Hoseyni M.S., et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 12 (2001) 519-528
23. Kanis J.A., Seeman E., Johnell O., Rizzoli R., and Delmas P. Letter. Osteoporosis international 17 (2006) 493-494
24. Jonsson B., Kanis J., Dawson A., Oden A., and Johnell O. Effect and offset of effect of treatments for hip fracture on health outcomes. Osteoporos Int 10 (1999) 193-199
25. Dargent-Molina P., Douchin M.N., Cormier C., Meunier P.J., and Breart G. Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS Prospective Study. Osteoporos Int 13 (2002) 593-599
26. Kanis J.A., Borgstrom F., De Laet C., Johansson H., Johnell O., Jonsson B., et al. Assessment of fracture risk. Osteoporos Int 16 (2005) 581-589
27. Dargent-Molina P., Piault S., and Breart G. A triage strategy based on clinical risk factors for selecting elderly women for treatment or bone densitometry: the EPIDOS prospective study. Osteoporos Int 16 (2005) 898-906
28. Johansson H., Oden A., Johnell O., Jonsson B., de Laet C., Oglesby A., et al. Optimization of BMD measurements to identify high risk groups for treatment-a test analysis. J Bone Miner Res 19 (2004) 906-913